Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://poppyiwwe121049.theisblog.com/40987376/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist